MBHB Partner Kevin Noonan Quoted In BioPharma-Reporter Article Entitled, “US FDA Stem Cell Enforcement Challenged By State Legislation”

McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin E. Noonan is quoted in a September 20, 2017 edition of BioPharma-Reporter in an article entitled, “US FDA stem cell enforcement challenged by state legislation.” State legislation allowing unapproved stem cell treatments could undermine efforts by the US FDA to clampdown on unregistered clinics. View the article